CLOSTRABIO
ClostraBio develops drugs that can prevent allergic reactions to food. It is dedicated to understanding and treating food allergies and other diseases of the immune system. The company is discovering and developing new therapeutics that modulate the protective ability of the microbe. ClostraBio’s scientific team has made key discoveries that highlight the importance of the intestinal microbiota in regulating allergic sensitization to food. The company is committed to a deeper understanding of the role of intestinal microbes in gut barrier function and determining the mechanisms of barrier protection.
CLOSTRABIO
Industry:
Biopharma Biotechnology Medical
Founded:
2016-01-01
Address:
Chicago, Illinois, United States
Country:
United States
Website Url:
http://www.clostrabio.com
Total Employee:
1+
Status:
Active
Total Funding:
3.54 M USD
Technology used in webpage:
SPF Google Font API LetsEncrypt Apache Google Apps For Business ReCAPTCHA AJAX Libraries API Unified Layer Hostgator Mail HostGator DNS
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Current Employees Featured
Founder
Investors List
Joseph Mansueto
Joseph Mansueto investment in Seed Round - ClostraBio
University of Chicago
University of Chicago investment in Seed Round - ClostraBio
Official Site Inspections
http://www.clostrabio.com Semrush global rank: 7.36 M Semrush visits lastest month: 515
- Host name: gator4075.hostgator.com
- IP address: 192.185.21.144
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092
More informations about "ClostraBio"
ClostraBio - Crunchbase Company Profile & Funding
ClostraBio develops drugs that can prevent allergic reactions to food. It is dedicated to understanding and treating food allergies and other diseases of …See details»
Team - ClostraBio, Inc.
Brett Newswanger Chief Operating Officer As COO at ClostraBio, Brett focuses on managing the company's product development activities and business operations. He previously spent …See details»
ClostraBio, Inc - LinkedIn
ClostraBio, Inc Biotechnology Research Chicago, IL 1,164 followers ClostraBio is dedicated to creating new dietary supplements and therapeutics for gut health, IBD and food allergy.See details»
About - ClostraBio, Inc.
Unmet Need and Solutions ClostraBio was founded based on work out of the University of Chicago, a world-leading academic institution. With an interest in the microbiome and its relationship to food allergy and other intestinal disorders, …See details»
ClostraBio 2025 Company Profile: Valuation, Funding
ClostraBio General Information Description. Developer of biopharmaceuticals intended to offer therapeutics for food allergies. The company's technology specializes in developing microbiome-modulating therapeutics and …See details»
ClostraBio - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Sep 30, 2022: Series A - …See details»
ClostraBio, Inc Overview | SignalHire Company Profile
ClostraBio, Inc is a private company that has been in the industry for 9 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the President …See details»
ClostraBio - 2025 Company Profile, Funding & Competitors - Tracxn
4 days ago ClostraBio - Developer of therapeutics to treat inflammatory bowel disease and food allergy. Raised a total funding of $14.4M over 4 rounds from 3 investors. Founded by Bruce …See details»
ClostraBio - VentureRadar
ClostraBio is dedicated to creating new therapeutics to treat inflammatory bowel disease (IBD) and food allergy. Our technology was spun out of the Nagler and Hubbell labs at the University …See details»
ClostraBio Company Profile - Office Locations, Competitors ... - Craft
ClostraBio is a biotech company focused on the development of treatment methods for food allergies and other diseases of the immune system. It explores the therapeutic potential of the …See details»
ClostraBio, Inc Company Profile | Chicago, IL - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ClostraBio, Inc of Chicago, IL. Get the latest business insights from Dun & Bradstreet.See details»
UChicago food allergy startup ClostraBio raises $3.5 million
Nagler’s new venture, ClostraBio, has made use of a variety of programs and resources offered by the University of Chicago’s Polsky Center for Entrepreneurship and Innovation and …See details»
Scientist builds drug development company out of research lab
Oct 27, 2016 ClostraBio was also a featured project at Polsky’s Sept. 26 Collaboratorium event, which allowed Nagler and Colson to recruit two Booth first-year MBA students—Renuka …See details»
ClostraBio: Revenue, Competitors, Alternatives - growjo.com
What Is ClostraBio? Utilizing a novel polymer platform for targeted delivery of bacterial metabolites to the gut, ClostraBio is dedicated to treating ulcerative colitis and food allergy. …See details»
ClostraBio Closes $4 Million Series A to Transform Intestinal Health ...
Oct 7, 2022 University of Chicago spinout ClostraBio has closed a $4 million Series A-1 financing round to accelerate development of its lead candidate, expand its plug-n-play …See details»
ClostraBio - Contacts, Employees, Board Members, Advisors
ClostraBio has 3 current employee profiles, including President and Co-Founder Cathryn R. Nagler. Cathryn R. Nagler President and Co-Founder Jeffrey A. Hubbell Co-Founder , Board …See details»
ClostraBio, Inc Company Information - Funding, Investors, and More
Track over 71,000 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.See details»
New UChicago Company Launched to Create First Food Allergy …
ClostraBio is a discovery- and preclinical-stage biopharmaceutical company creating some of the first drugs to prevent and treat life-threatening food allergies by harnessing the power of the …See details»
Meet the Polsky Center Startup Taking on Food Allergies
May 9, 2019 ClostraBio draws on Nagler’s scientific research and aims to create microbiome-based treatments for people with life-threatening food allergies—an increasingly important …See details»
ClostraBio Gains INVENT Illinois Investment, Appoints New CSO ...
5 days ago ClostraBio was spun out of the University of Chicago in 2016 and has since grown to 5 full-time employees and multiple fractional consultants while working out of Portal Innovations.See details»